PHARMACYTE BIOTECH, INC. Gain (Loss) Related to Litigation Settlement
PHARMACYTE BIOTECH, INC. (PMCB) reported Gain (Loss) Related to Litigation Settlement of $1.31 million for the 3-month period ending 2013-07-31, per its 10-Q filed 2013-09-16.
Discontinued › Income Statement › Other Income
us-gaap:GainLossRelatedToLitigationSettlement · last filed 2013-09-16
- PHARMACYTE BIOTECH, INC. gain (loss) related to litigation settlement for the quarter ending 2013-07-31 was $1.31M.
| Period end | Gain (Loss) Related to Litigation Settlement 3 month |
|---|---|
| 2013-07-31 | $1.31M 10-Q · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |